Tibes R, Giles F, McQueen T, Bergstrom DA, Freedman SJ, Andreeff M
The Food and Drug Administration declared the shortage over in 2025, yet telehealth companies still sell compounded versions of the anti-obesity drugs, tailoring the medications to different dosages and often selling them for less than what pharmaceutical companies charge for the brand-name drugs
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice
Inflammation in the central nervous system can further contribute to signaling changes and systemic insulin resistance
Pancreas 22:102-195, 2001
Instead of pushing you to the maximum tolerated dose for short-term weight loss, Dr